1 – 10 of 720
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2022
- Safety of pre- or postoperative accelerated radiotherapy in 5 fractions : a randomized pilot trial (2022) BREAST. 62. p.10-15
- Distinct transcriptional programs of ascitic and solid cancer cells induce a different response to chemotherapy in high-grade serous ovarian cancer (2022) Molecular Cancer Research.
- Distinct transcriptional programs in ascitic and solid cancer cells induce different responses to chemotherapy in high-grade serous ovarian cancer (2022) Molecular Cancer Research.
- A clearer view on ovarian clear cell carcinoma (2022) ACTA CLINICA BELGICA.
- Extrauterine mesonephric-like neoplasms : expanding the morphologic spectrum (2022) AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 46(1). p.124-133
- Malignant pleural mesothelioma with an EML4-ALK fusion : expect the unexpected! (2022) PATHOLOGY RESEARCH AND PRACTICE. 231.
- Shallow whole-genome sequencing : a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue : a glioma-driven study (2022) VIRCHOWS ARCHIV. 480. p.677-686
- European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer (2022) ANNALS OF ONCOLOGY. 33(3). p.276-287
- Update to the Belgian follow-up guidelines for abnormal cervical screening results (2022) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 16(2). p.60-69
- The added value of peroral cholangioscopy to diagnose intraductal papillary neoplasm of the bile duct (2022) Endoscopy.